# Bristol-Myers Squibb Company (BMY) — Q4-2018 Earnings Results

**Report date:** 2019-01-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2018

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 1.88%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.94 | N/A | +3.11% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their strategic direction. They acknowledged challenges but remained focused on delivering value.

**Key quotes:**

> Management highlighted the continued strength of their product pipeline.

> They emphasized a focus on innovation and long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 1.88%, possibly due to a lack of revenue data and no guidance for the future. Investors may be cautious as they await more information on the company's performance and outlook.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2018_